269 related articles for article (PubMed ID: 25239453)
21. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
Zvelebil M; Oliemuller E; Gao Q; Wansbury O; Mackay A; Kendrick H; Smalley MJ; Reis-Filho JS; Howard BA
Breast Cancer Res; 2013 Mar; 15(2):R25. PubMed ID: 23506684
[TBL] [Abstract][Full Text] [Related]
22. RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.
Palafox M; Ferrer I; Pellegrini P; Vila S; Hernandez-Ortega S; Urruticoechea A; Climent F; Soler MT; Muñoz P; Viñals F; Tometsko M; Branstetter D; Dougall WC; González-Suárez E
Cancer Res; 2012 Jun; 72(11):2879-88. PubMed ID: 22496457
[TBL] [Abstract][Full Text] [Related]
23. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract][Full Text] [Related]
24. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
Nolan E; Vaillant F; Branstetter D; Pal B; Giner G; Whitehead L; Lok SW; Mann GB; ; Rohrbach K; Huang LY; Soriano R; Smyth GK; Dougall WC; Visvader JE; Lindeman GJ
Nat Med; 2016 Aug; 22(8):933-9. PubMed ID: 27322743
[TBL] [Abstract][Full Text] [Related]
25. Cell fate takes a slug in BRCA1-associated breast cancer.
Lindeman GJ; Visvader JE
Breast Cancer Res; 2011 Apr; 13(2):306. PubMed ID: 21489318
[TBL] [Abstract][Full Text] [Related]
26. R-spondin3 Is Associated with Basal-Progenitor Behavior in Normal and Tumor Mammary Cells.
Tocci JM; Felcher CM; García Solá ME; Goddio MV; Zimberlin MN; Rubinstein N; Srebrow A; Coso OA; Abba MC; Meiss RP; Kordon EC
Cancer Res; 2018 Aug; 78(16):4497-4511. PubMed ID: 29748375
[TBL] [Abstract][Full Text] [Related]
27. EZH2 Is Overexpressed in
Puppe J; Opdam M; Schouten PC; Jóźwiak K; Lips E; Severson T; van de Ven M; Brambillasca C; Bouwman P; van Tellingen O; Bernards R; Wesseling J; Eichler C; Thangarajah F; Malter W; Pandey GK; Ozretić L; Caldas C; van Lohuizen M; Hauptmann M; Rhiem K; Hahnen E; Reinhardt HC; Büttner R; Mallmann P; Schömig-Markiefka B; Schmutzler R; Linn S; Jonkers J
Clin Cancer Res; 2019 Jul; 25(14):4351-4362. PubMed ID: 31036541
[TBL] [Abstract][Full Text] [Related]
28. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
29. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.
Wang H; Xiang D; Liu B; He A; Randle HJ; Zhang KX; Dongre A; Sachs N; Clark AP; Tao L; Chen Q; Botchkarev VV; Xie Y; Dai N; Clevers H; Li Z; Livingston DM
Cell; 2019 Jun; 178(1):135-151.e19. PubMed ID: 31251913
[TBL] [Abstract][Full Text] [Related]
30. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
[TBL] [Abstract][Full Text] [Related]
31. BRCA1 mutations and luminal-basal transformation.
Ng T; Irshad S; Stebbing J
Oncogene; 2013 May; 32(22):2712-4. PubMed ID: 22926516
[TBL] [Abstract][Full Text] [Related]
32. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
[TBL] [Abstract][Full Text] [Related]
33. Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in
Hu L; Su L; Cheng H; Mo C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Zhang J; Xie Y
Cancer Res; 2021 May; 81(10):2600-2611. PubMed ID: 33727227
[TBL] [Abstract][Full Text] [Related]
34. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
Wang H; Bierie B; Li AG; Pathania S; Toomire K; Dimitrov SD; Liu B; Gelman R; Giobbie-Hurder A; Feunteun J; Polyak K; Livingston DM
Mol Cell; 2016 Jul; 63(2):277-292. PubMed ID: 27373334
[TBL] [Abstract][Full Text] [Related]
35. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
36. iPSC-Derived Hereditary Breast Cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract][Full Text] [Related]
37. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å
Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203
[TBL] [Abstract][Full Text] [Related]
38. BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.
Buckley NE; Mullan PB
Stem Cell Rev Rep; 2012 Sep; 8(3):982-93. PubMed ID: 22426855
[TBL] [Abstract][Full Text] [Related]
39. Nalbuphine suppresses breast cancer stem-like properties and epithelial-mesenchymal transition via the AKT-NFκB signaling pathway.
Yu J; Luo Y; Wen Q
J Exp Clin Cancer Res; 2019 May; 38(1):197. PubMed ID: 31092275
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 mutation influences progesterone response in human benign mammary organoids.
Davaadelger B; Choi MR; Singhal H; Clare SE; Khan SA; Kim JJ
Breast Cancer Res; 2019 Nov; 21(1):124. PubMed ID: 31771627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
